Belharra Therapeutics

0 followers

Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational sta... Read more

Employees

11-50

Links


Org chart

Collapse
Gary O’Neill
Chief Scientific Officer
Rachel Lane
Chief Business Officer
Sharon Tetlow
Interim CFO
Sean Buchanan
Chief Scientific Officer
Yvonne Schmidt
Senior Director
Alice Chen
Senior Scientist II
Lisa Allen
Head Of Talent

Board & advisors

John Teijaro
Co-Founder
Ben Cravatt
Co-Founder & Director
Tom Woiwode
Director